Open AccessCheckpoint inhibitors first in patients with metastatic non-small cell lung cancer harboring BRAFV600E mutation with PD-L1 90%—a debate in a niche population
Author(s) -
Yusra F. Shao,
Ammar Sukari,
Misako Nagasaka
Publication year - 2020
Publication title -
precision cancer medicine
Language(s) - English
Resource type - Journals
ISSN - 2617-2216
DOI - 10.21037/pcm-20-60
Subject(s) - mutation , medicine , niche , cancer research , lung cancer , population , oncology , biology , genetics , gene , environmental health , ecology